EcoDrugPlus

Receptor-Type Tyrosine-Protein Phosphatase Beta-Like

Ensembl ID : ENSSMAG00000019806
Gene Symbol: LOC118315797
2 Cross references
203 Possible Orthologues:

Regulatory Associated Protein Of Mtor Complex 1

Ensembl ID : ENSSMAG00000011312
Gene Symbol: RPTOR
1 Cross references
213 Possible Orthologues:

Renin

Ensembl ID : ENSSMAG00000010970
Gene Symbol: REN
2 Cross references
219 Possible Orthologues:

Ret Proto-Oncogene Receptor Tyrosine Kinase

Ensembl ID : ENSSMAG00000012975
Gene Symbol: RET
3 Cross references
205 Possible Orthologues:

Retinoic Acid Receptor Beta

Ensembl ID : ENSSMAG00000020130
Gene Symbol: RARB
3 Cross references
393 Possible Orthologues:

Retinoic Acid Receptor Beta-Like

Ensembl ID : ENSSMAG00000014046
Gene Symbol: LOC118285423
2 Cross references
380 Possible Orthologues:

Retinoic Acid Receptor Gamma A

Ensembl ID : ENSSMAG00000004391
Gene Symbol: RARGA
2 Cross references
325 Possible Orthologues:

Retinoid X Receptor, Alpha A

Ensembl ID : ENSSMAG00000015755
Gene Symbol: RXRAA
2 Cross references
225 Possible Orthologues:

Retinoid X Receptor, Beta B

Ensembl ID : ENSSMAG00000000277
Gene Symbol: RXRBB
3 Cross references
211 Possible Orthologues:

Ribosomal Protein L10

Ensembl ID : ENSSMAG00000001919
Gene Symbol: RPL10
2 Cross references
405 Possible Orthologues:

Ribosomal Protein L10a

Ensembl ID : ENSSMAG00000019351
Gene Symbol: RPL10A
3 Cross references
366 Possible Orthologues:

Ribosomal Protein L11

Ensembl ID : ENSSMAG00000018435
Gene Symbol: RPL11
1 Cross references
288 Possible Orthologues:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).